Conditional Coverage/Access with Evidence Development

HTAi Interest Group on Conditional Coverage and Evidence Development for Promising Technologies

Go to IG blog

Message from the IG Chair:

Health Technology Assessment International and the Center for Medical Technology Policy are pleased to lead a blog that will support regulator communication and information sharing for the IG on Conditional Coverage/Access with Evidence Development.  

This site will provide a simple platform through which IG members can easily follow recent news and share information on CED, AED and related forms of conditional coverage and “managed entry”.

To begin with, we plan to post a blog entry on the site every few weeks, and an email notification will be sent to all IG listserv members. Our hope is that these posts will stimulate discussion among IG members and can serve as a forum for sharing information and advancing work on these topics. We also welcome suggestions for future topics and content.   The web site will allow you to send an email to the Blog Moderator listed on the Contact page, which will then be posted on the site.  You are encouraged to send links to interesting articles, presentations, meetings, etc, and feel free to write a short comment or blog that others may be of interest to other IG members.

Please be sure to subscribe to the blog by entering your email address on the right side of the home page.

Thank you for your continued interest, and we look forward to a robust exchange of ideas and information among IG members.

Sean Tunis, Center for Medical Technology Policy

IG Materials

Members, login to access IG materials (login top at right of this page).

Join this IG

IG chair: Sean Tunis

As of 2012, the IG has over 250 members!

All members of HTAi are welcome to participate in this IG. To join, simply log in to the website and return to this page. A link to join the IG mailing list will appear automatically. 

Non-members of HTAi are also welcome express interest in joining this IG, with membership pending approval of the IG chair. For enquiries, please contact the HTAi Secretariat.